Obesity and Risk of Recurrence in Patients With Breast Cancer Treated With Aromatase Inhibitors

IMPORTANCE: Clinical studies confirm that obesity is a risk factor for recurrence in postmenopausal women with hormone receptor–positive (HR+) breast cancer. Evidence suggests that women with obesity do not obtain similar protection from aromatase inhibitors as women with healthy weight. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Harborg, Sixten, Cronin-Fenton, Deirdre, Jensen, Maj-Britt Raaby, Ahern, Thomas P., Ewertz, Marianne, Borgquist, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576219/
https://www.ncbi.nlm.nih.gov/pubmed/37831449
http://dx.doi.org/10.1001/jamanetworkopen.2023.37780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576219/
https://www.ncbi.nlm.nih.gov/pubmed/37831449
http://dx.doi.org/10.1001/jamanetworkopen.2023.37780

Ejemplares similares